ensun logo
Locations
Company type
Result types
Industries
Employees
Founding year
Vertex Pharmaceuticals Logo

Vertex Pharmaceuticals

We’re focused on discovering, developing and producing innovative medicines so people with serious diseases can lead better lives. The European Commission (EC) approves our CRISPR-based treatment for sickle cell disease and transfusion-dependent beta thalassemia for the European Union. Our company is built on an inclusive culture that brings together the best and brightest in every field striving for one goal: to improve the lives of people with serious diseases. Learn more about how we're dedicated to being responsible global citizens from Executive Director Katharine Jensen.

Quick overview

Boston, United States

Founded in 1989

1001-5000 Employees

Additional information

Working industry

Biotechnology

Type of company

Educational institution

Ownership structure

Public Company

Locations

5 Locations

Number of products

1 Product

Specialised areas

Scientific Research and Development Services, Manufacturing, Pharmaceutical preparations Biotechnical research, commercial, Pharmaceutical, Pharmaceutical preparations, Medical, Biotechnology, Chemical Manufacturing, Pharmaceutical and Medicine Manufacturing, Health Care

Products & services of Vertex Pharmaceuticals

Vertex Pharmaceuticals offers a wide range of products and services

Product: Vertex Pharmaceuticals | Medicines | Reporting Adverse Events and/or Product Complaints

Product

Vertex Pharmaceuticals | Medicines | Reporting Adverse Events and/or Product Complaints

Go to product >

ESG score estimation

An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself

Country:

United States


Overall risk estimation:

Low


ESG country scores

The ESG Data of countries are based on public sources

Environment

D

Grade (A-E)

View details

Social

A

Grade (A-E)

View details

Governance

A

Grade (A-E)

View details

Headquarter of Vertex Pharmaceuticals

Vertex Pharmaceuticals operates in 4 countries around the world

City: Boston

State: Massachusetts

Country: United States

Locations of Vertex Pharmaceuticals

Get an overview of the locations of Vertex Pharmaceuticals

Location

Country

State

City

Headquarter

United States

Massachusetts

Boston

Research & Development Site

United States

California

San Diego

Research & Development Site

United Kingdom

-

-

Spain Office

Spain

Community of Madrid

Madrid

Australia Office

Australia

New South Wales

Sydney

Frequently asked questions (FAQ) about Vertex Pharmaceuticals

Some frequent questions that have been asked about Vertex Pharmaceuticals

The company headquarter of Vertex Pharmaceuticals is located in Boston, Massachusetts, United States. Vertex Pharmaceuticals has subsidiaries in United States, United Kingdom, Spain, Australia

As of the latest available information Vertex Pharmaceuticals has around 1001-5000 employees worldwide.

Vertex Pharmaceuticals was founded in 1989

The company Vertex Pharmaceuticals has it's main focus in the industries of Biotechnology

Competitors of Vertex Pharmaceuticals

Check out some interesting alternative companies to Vertex Pharmaceuticals

BridgeBio Pharma's Logo

BridgeBio Pharma

Palo Alto, United States

251-500 Employees

2014

To discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. The opportunity to help patients with genetic disease is vast. There are more than 8,000 diseases caused by a single genetic mutation. In total they affect tens of millions of people, but less than 50 FDA approved therapies exist to treat this class of conditions. By capitalizing on scientific advancements that deepen our understanding of genetic diseases, we have the potential to develop breakthrough medicines for patients in need at an unprecedented scale.

Kriya Therapeutics's Logo

Kriya Therapeutics

Palo Alto, United States

51-100 Employees

2019

We are developing life-changing gene therapies for conditions affecting millions of people around the world. Our mission is to make gene therapies accessible – not just for the few – but for the many. We are located in Palo Alto, California and Research Triangle Park, North Carolina. We are backed by leading healthcare and technology investors who are committed to our goal of building the world’s leading gene therapy biopharmaceutical company. We target validated biological pathways with innovative gene therapy approaches that have the potential to deliver transformative benefits.

Scopus BioPharma's Logo

Scopus BioPharma

New York, United States

1-10 Employees

2018

We are a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. Our mission is to improve patient outcomes and save lives. To achieve our mission, we are capitalizing on groundbreaking scientific and medical discoveries at some of the world’s foremost research and academic institutions.

Celgene's Logo

Celgene

United States

10001+ Employees

1986

We are a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are proud of the advancements we have made in oncology, hematology, immunology and cardiovascular disease, and we are dedicated to helping patients prevail over serious diseases through our diverse and promising pipeline and new scientific platforms. We are pursuing therapies at the forefront of scientific discovery with the goal of bringing an exciting new generation of life-changing treatments to patients. Our shared values are central to who we are, what we do and how we do it.

StrideBio's Logo

StrideBio

Durham, United States

51-100 Employees

2015

Our mission is to develop best-in-class gene therapies for people with life-threatening diseases. Our vision is to be the leader in the evolution of gene therapy and be known for superior drug development, high industry standards, extraordinary integrity and an innovative team that translates science into treatments that prolong and improve lives.

CRISPR Therapeutics's Logo

CRISPR Therapeutics

Cambridge, United States

101-250 Employees

2013

We are pioneering a new era of medicines. We are pioneers of the CRISPR technology and at the forefront of what’s next. The first-ever CRISPR-based therapy is a direct reflection of our patient-forward philosophy. We believe this once-in-a-generation breakthrough will make an impact for generations to come. CRISPR Therapeutics is founded, launching the growth of our team focused on translating the CRISPR/Cas9 discovery into potential therapeutics. Opens the doors to its own manufacturing facility in Framingham, Massachusetts. Where we’ve built our state-of-the-art, award-winning manufacturing facility.*. Here we focus on the most advanced gene editing and delivery technologies of the future.